Trademark: 90843674
Word
BRAIN-TO-BRAIN
Status
Pending
Status Code
731
Status Date
Wednesday, November 22, 2023
Serial Number
90843674
Mark Type
4000
Filing Date
Thursday, July 22, 2021
Published for Opposition
Tuesday, September 27, 2022

Trademark Owner History
Neuroenhancement Lab, Inc. - Owner At Publication

Classifications
9 Computer hardware and recorded software sold as a unit for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; Downloadable medical software for controlling a sensory stimulation device, neuromodulation device, or photobiomodulation device for analyzing current brain state, storing brainwaves, and modulating light or sound with signals, all for altering a mental state, determining a sleep stage, treating insomnia, treating sleep disorders, treating depression, treating anxiety, treating neurodegenerative diseases, treating Alzheimer's disease, treating dementia, treating Parkinson's disease, treating post-traumatic stress disorder, treating phobias, treating addictions, treating attention deficit hyperactivity disorder, treating autism, treating mood disorders, treating brain disorders, treating central nervous system disorders, providing emotional enhancement, accelerating learning, storing brainwaves; Downloadable software for implementing a social network interface; Downloadable scientific and medical data via the Internet; Downloadable Software as a Medical Device (SaMD) for treating insomnia, sleep disorders, depression, anxiety, neurodegenerative diseases, Alzheimer's disease, dementia, Parkinson's disease, post-traumatic stress disorder, phobias, addictions, attention deficit hyperactivity disorder, autism, mood disorders, brain disorders, central nervous system disorders; Downloadable Software as a Medical Device (SaMD) for use as a medical instrument for controlling a sensory stimulation device, neuromodulation device, or photobiomodulation device for modulating light or sound with signals, all for altering a mental state, determining a sleep stage, treating insomnia, treating sleep disorders, treating depression, treating anxiety, treating neurodegenerative diseases, treating Alzheimer's disease, treating dementia, treating Parkinson's disease, treating post-traumatic stress disorder, treating phobias, treating addictions, treating attention deficit hyperactivity disorder, treating autism, treating mood disorders, treating brain disorders, treating central nervous system disorders, providing emotional enhancement, providing accelerated learning; Recorded medical software for controlling a sensory stimulation device, neuromodulation device, or photobiomodulation device for modulating light or sound with signals, all for altering a mental state, determining a sleep stage, treating insomnia, treating sleep disorders, treating depression, treating anxiety, treating neurodegenerative diseases, treating Alzheimer's disease, treating dementia, treating Parkinson's disease, treating post-traumatic stress disorder, treating phobias, treating addictions, treating attention deficit hyperactivity disorder, treating autism, treating mood disorders, treating brain disorders, treating central nervous system disorders, providing emotional enhancement, providing accelerated learning; Recorded Software as a Medical Device (SaMD) for treating insomnia, sleep disorders, depression, anxiety, neurodegenerative diseases, Alzheimer's disease, dementia, Parkinson's disease, post traumatic stress disorder, phobias, addictions, attention deficit hyperactivity disorder, autism, mood disorders, brain disorders, central nervous system disorders; Recorded Software as a Medical Device (SaMD) for use as a medical instrument for controlling a sensory stimulation device, neuromodulation device, or photobiomodulation device for analyzing current brain state, storing brainwaves, and modulating light or sound with signals, all for altering a mental state, determining a sleep stage, treating insomnia, treating sleep disorders, treating depression, treating anxiety, treating neurodegenerative diseases, treating Alzheimer's disease, treating dementia, treating Parkinson's disease, treating post-traumatic stress disorder, treating phobias, treating addictions, treating attention deficit hyperactivity disorder, treating autism, treating mood disorders, treating brain disorders, treating central nervous system disorders, providing emotional enhancement, providing accelerated learning

Trademark Events
Nov 24, 2023
Notice Of Approval Of Extension Request E-Mailed
Nov 22, 2023
Sou Extension 2 Granted
Nov 22, 2023
Sou Extension 2 Filed
Nov 22, 2023
Sou Teas Extension Received
May 24, 2023
Notice Of Approval Of Extension Request E-Mailed
May 22, 2023
Sou Extension 1 Granted
May 22, 2023
Sou Extension 1 Filed
May 22, 2023
Sou Teas Extension Received
Nov 22, 2022
Noa E-Mailed - Sou Required From Applicant
Sep 27, 2022
Official Gazette Publication Confirmation E-Mailed
Sep 27, 2022
Published For Opposition
Sep 7, 2022
Notification Of Notice Of Publication E-Mailed
Aug 24, 2022
Approved For Pub - Principal Register
Jul 23, 2022
Teas/Email Correspondence Entered
Jul 22, 2022
Correspondence Received In Law Office
Jul 22, 2022
Teas Response To Office Action Received
Apr 11, 2022
Notification Of Non-Final Action E-Mailed
Apr 11, 2022
Non-Final Action E-Mailed
Apr 11, 2022
Non-Final Action Written
Apr 11, 2022
Removed From Teas Plus
Mar 29, 2022
Assigned To Examiner
Sep 23, 2021
New Application Office Supplied Data Entered
Jul 26, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24